UBS Reiterates Buy Rating on BioNTech (BNTX) Following Lung Cancer Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. META
2. NVDA
3. SPY
4. VRTX
5. LGND
6. ONON
7. USO
8. PSKY
9. MONC:IM
10. PTON

Go back to UBS Reiterates Buy Rating on BioNTech (BNTX) Following Lung Cancer Updates
(NASDAQ: BNTX) Delayed: 102.01 +4.01 (4.09%)
Previous Close $98.00    52 Week High $ 
Open $98.00    52 Week Low $ 
Day High $102.23    P/E N/A 
Day Low $97.46    EPS $ 
Volume 290,110